Profile data is unavailable for this security.
About the company
Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.
- Revenue in SEK (TTM)8.40m
- Net income in SEK-188.37m
- Incorporated2007
- Employees83.00
- LocationQ linea ABDag Hammarskjolds Vag 52 AUPPSALA 752 37SwedenSWE
- Phone+46 184443610
- Websitehttps://www.qlinea.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prolight Diagnostics AB (publ) | 0.00 | -35.57m | 234.63m | 21.00 | -- | 1.29 | -- | -- | -4.03 | -4.03 | 0.00 | 15.08 | 0.00 | -- | -- | 0.00 | -19.97 | -- | -24.07 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 80.11 | -- | -1.65 | -- |
| Integrum AB | 97.00m | -29.85m | 236.07m | 37.00 | -- | 1.25 | -- | 2.43 | -1.37 | -1.37 | 4.50 | 7.26 | 0.5253 | 0.828 | 3.40 | 2,487,052.00 | -16.17 | -3.58 | -17.87 | -4.08 | 75.61 | 83.88 | -30.78 | -6.47 | 1.88 | -- | 0.025 | -- | -12.50 | 27.78 | -864.22 | -- | 103.14 | -- |
| Karolinska Development AB | 1.74m | -135.74m | 239.45m | 8.00 | -- | 0.0775 | -- | 137.77 | -0.4096 | -0.4096 | 0.0052 | 3.28 | 0.0015 | -- | 0.6263 | 217,250.00 | -11.69 | -2.23 | -11.78 | -2.37 | -- | -- | -7,810.36 | -1,161.99 | -- | -1.49 | 0.0017 | -- | -8.74 | -11.49 | -250.41 | -- | -- | -- |
| Clinical Laserthermia Systems AB | 21.27m | -38.38m | 241.52m | 16.00 | -- | 3.34 | -- | 11.36 | -5.02 | -5.02 | 1.08 | 2.32 | 0.3208 | 4.58 | 4.84 | 1,329,313.00 | -57.98 | -116.28 | -63.60 | -248.44 | -63.75 | -556.78 | -180.75 | -872.82 | 2.55 | -5.79 | 0.0039 | -- | 127.04 | 67.47 | 40.32 | -- | -- | -- |
| ContextVision AB | 112.78m | 3.58m | 266.42m | 44.00 | 75.15 | 2.94 | 23.34 | 2.36 | 0.0496 | 0.0496 | 1.60 | 1.27 | 0.9575 | 1.74 | 4.15 | 3,053,534.00 | 3.04 | 30.51 | 3.71 | 45.07 | 97.62 | 98.49 | 3.17 | 28.49 | 4.70 | -- | 0.0847 | -- | -1.15 | 6.51 | -24.60 | 27.25 | -30.69 | -- |
| Acarix AB | 6.92m | -52.44m | 291.50m | 8.00 | -- | 7.57 | -- | 42.14 | -0.0472 | -0.0472 | 0.0062 | 0.0343 | 0.1196 | 0.1667 | 2.77 | 864,750.00 | -90.68 | -74.33 | -102.27 | -86.47 | 86.15 | 82.37 | -757.98 | -1,298.77 | 7.93 | -805.72 | 0.00 | -- | -0.6249 | 27.28 | 14.97 | -- | -- | -- |
| INIFY Laboratories AB | 20.16m | -61.47m | 317.43m | 34.00 | -- | 2.42 | -- | 15.75 | -1.16 | -1.16 | 0.377 | 1.75 | 0.1928 | 2.96 | 3.12 | 873,195.00 | -58.78 | -- | -58.78 | -- | 85.20 | -- | -304.93 | -- | -- | -- | 0.00 | -- | 1,000.67 | -- | 3.15 | -- | -- | -- |
| Mentice AB | 274.49m | -43.31m | 369.85m | 121.00 | -- | 2.94 | -- | 1.35 | -1.68 | -1.68 | 10.52 | 4.48 | 0.9663 | 1.60 | 3.94 | 2,095,328.00 | -15.25 | -6.64 | -31.60 | -11.91 | 90.40 | 84.80 | -15.78 | -8.53 | 0.845 | -30.10 | 0.116 | -- | 6.11 | 14.22 | -553.89 | -- | 32.86 | -- |
| Q linea AB | 8.40m | -188.37m | 450.99m | 83.00 | -- | 1.88 | -- | 53.72 | -93.10 | -93.10 | 2.12 | 12.69 | 0.0571 | 0.5409 | 4.37 | 89,308.51 | -128.17 | -71.92 | -306.62 | -84.15 | -110.15 | -303.58 | -2,243.85 | -3,994.18 | 1.28 | -62.88 | 0.3537 | -- | -46.80 | 18.64 | 5.45 | -- | -49.88 | -- |
| Ortoma AB | 77.19m | -7.52m | 467.54m | 10.00 | -- | 2.97 | 89.54 | 6.06 | -0.2027 | -0.2027 | 2.08 | 4.45 | 0.4243 | 3.95 | 39.13 | 7,530,537.00 | -4.13 | -9.37 | -4.45 | -10.43 | 41.26 | 158.24 | -9.74 | -78.90 | 3.02 | -- | 0.00 | -- | 28.77 | -- | 46.83 | -- | -0.5751 | -- |
| Bactiguard Holding AB | 231.46m | -21.28m | 513.78m | 157.00 | -- | 1.92 | 19.93 | 2.22 | -0.6072 | -0.6072 | 6.60 | 8.60 | 0.3792 | 3.43 | 7.12 | 1,307,684.00 | -3.49 | -8.74 | -5.08 | -10.70 | 59.14 | 46.42 | -9.19 | -28.84 | 1.04 | -2.18 | 0.3553 | -- | 17.34 | 6.19 | 78.45 | -- | 27.29 | -- |
| Modulight Oyj | 72.17m | -49.21m | 519.29m | 71.00 | -- | 1.07 | -- | 7.20 | -0.1172 | -0.1172 | 0.1727 | 1.07 | 0.1254 | -0.7943 | 4.78 | 102,484.90 | -8.55 | -9.90 | -9.25 | -10.66 | 129.94 | 119.43 | -68.15 | -88.50 | 3.46 | -- | 0.081 | -- | 1.74 | -10.65 | 45.65 | -- | 24.38 | -- |
| Nanexa AB | 10.58m | -39.06m | 587.10m | 15.00 | -- | 7.59 | -- | 55.51 | -0.2644 | -0.2644 | 0.0694 | 0.4874 | 0.0972 | 24.67 | 1.54 | 813,538.40 | -35.91 | -37.21 | -42.59 | -44.95 | 69.56 | 93.79 | -369.29 | -355.05 | 2.07 | -21.98 | 0.2165 | -- | -16.93 | 70.11 | 67.40 | -- | 21.42 | -- |
Data as of Feb 06 2026. Currency figures normalised to Q linea AB's reporting currency: Swedish Krona SEK
2.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 21 Feb 2025 | 200.05k | 1.06% |
| Handelsbanken Fonder ABas of 31 Dec 2025 | 114.38k | 0.60% |
| Investment AB �resund (Investment Management)as of 31 Dec 2024 | 55.61k | 0.29% |
| FCG Fonder ABas of 31 Mar 2025 | 14.17k | 0.08% |
| Storebrand Asset Management ASas of 30 Nov 2025 | 3.78k | 0.02% |
| Danske Bank A/S (Investment Management)as of 31 Dec 2025 | 2.72k | 0.01% |
| SEB Funds ABas of 29 Jan 2025 | 766.00 | 0.00% |
More ▼
Data from 31 Dec 2024 - 31 Dec 2025Source: FactSet Research Systems Inc.
